Patents by Inventor Ethan Grant

Ethan Grant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD40L ANTAGONIST AND USES THEREOF
    Publication number: 20250019408
    Abstract: A human CD40L-specific Tn3 molecule and therapeutic uses thereof.
    Type: Application
    Filed: March 21, 2024
    Publication date: January 16, 2025
    Inventors: Jorn DRAPPA, Marius ALBULESCU, Jing LI, Ethan GRANT, Katie STREICHER, Gabor G. ILLEI, Liangwei WANG, William A. REES
  • CD40L ANTAGONIST AND USES THEREOF
    Publication number: 20210340200
    Abstract: A human CD40L-specific Tn3 molecule and therapeutic uses thereof.
    Type: Application
    Filed: September 25, 2019
    Publication date: November 4, 2021
    Inventors: Jorn DRAPPA, Marius ALBULESCU, Jing LI, Ethan GRANT, Katie STREICHER, Gabor ILLEI, Liangwei WANG, William REES
  • Methods of using antibodies to determine periostin levels in a sample
    Patent number: 10775388
    Abstract: This disclosure provides a robust, sensitive, and specific assay for the detection and measurement of periostin levels in samples obtained from human patients having, or suspected of having an IL-13-mediated disease or disorder. The disclosure further provides novel antiperiostin monoclonal antibodies that recognize at least isoforms 1, 2, 3, 4, 7, and 8 of human periostin, and assay kits comprising one or more of these antibodies.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: September 15, 2020
    Assignees: MEDIMMUNE, LLC, ABBOTT LABORATORIES
    Inventors: Partha S. Chowdhury, Reena Varkey, Meina Liang, Yen-Wah Lee, Katie Streicher, Koustubh Ranade, Ethan Grant, Lydia Greenlees, Yihong Yao, Melissa Parker, Gerard Davis, Nicolette Jeanblanc, Susan Brophy, Bruce Dille
  • NOVEL ASSAY TO DETECT HUMAN PERIOSTIN
    Publication number: 20180196065
    Abstract: This disclosure provides a robust, sensitive, and specific assay for the detection and measurement of periostin levels in samples obtained from human patients having, or suspected of having an IL-13-mediated disease or disorder. The disclosure further provides novel antiperiostin monoclonal antibodies that recognize at least isoforms 1, 2, 3, 4, 7, and 8 of human periostin, and assay kits comprising one or more of these antibodies.
    Type: Application
    Filed: February 5, 2015
    Publication date: July 12, 2018
    Inventors: Partha Chowdhury, Reena Varkey, Meina Liang, Yen-Wah Lee, Katie Streicher, Koustubh Ranade, Ethan Grant, Lydia Greenlees, Yihong Yao, Melissa Parker, Gerard Davis, Nicolette Jeanblanc, Susan Brophy, Bruce Dille
  • NOVEL ASSAY TO DETECT HUMAN PERIOSTIN
    Publication number: 20180179272
    Abstract: This disclosure provides a robust, sensitive, and specific assay for the detection and measurement of periostin levels in samples obtained from human patients having, or suspected of having an IL-13-mediated disease or disorder. The disclosure further provides novel antiperiostin monoclonal antibodies that recognize at least isoforms 1, 2, 3, 4, 7, and 8 of human periostin, and assay kits comprising one or more of these antibodies.
    Type: Application
    Filed: November 22, 2017
    Publication date: June 28, 2018
    Inventors: Partha Chowdhury, Reena Varkey, Meina Liang, Yen-Wah Lee, Katie Streicher, Koustubh Ranade, Ethan Grant, Lydia Greenlees, Yihong Yao, Melissa Parker
  • Monoclonal antibodies which bind human periostin
    Patent number: 9862762
    Abstract: This disclosure provides a robust, sensitive, and specific assay for the detection and measurement of periostin levels in samples obtained from human patients having, or suspected of having an IL-13-mediated disease or disorder. The disclosure further provides novel antiperiostin monoclonal antibodies that recognize at least isoforms 1, 2, 3, 4, 7, and 8 of human periostin, and assay kits comprising one or more of these antibodies.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: January 9, 2018
    Assignee: MEDIMMUNE, LLC
    Inventors: Partha Chowdhury, Reena Varkey, Meina Liang, Yen-Wah Lee, Katie Streicher, Koustubh Ranade, Ethan Grant, Lydia Greenlees, Yihong Yao, Melissa Parker
  • NOVEL ASSAY TO DETECT HUMAN PERIOSTIN
    Publication number: 20160311894
    Abstract: This disclosure provides a robust, sensitive, and specific assay for the detection and measurement of periostin levels in samples obtained from human patients having, or suspected of having an IL-13-mediated disease or disorder. The disclosure further provides novel antiperiostin monoclonal antibodies that recognize at least isoforms 1, 2, 3, 4, 7, and 8 of human periostin, and assay kits comprising one or more of these antibodies.
    Type: Application
    Filed: February 5, 2015
    Publication date: October 27, 2016
    Inventors: Partha Chowdhury, Reena Varkey, Meina Liang, Yen-Wah Lee, Katie Streicher, Koustubh Ranade, Ethan Grant, Lydia Greenlees, Yihong Yao, Melissa Parker
  • Method for treating B cell regulated autoimmune disorders
    Publication number: 20070032493
    Abstract: The invention relates to a method for treating B-cell regulated autoimmune disorders using compounds that modulate the activity of c-Rel.
    Type: Application
    Filed: May 26, 2006
    Publication date: February 8, 2007
    Applicant: Synta Pharmaceuticals Corp.
    Inventors: Kevin Foley, John Bertin, Ethan Grant